Monthly release covers the period from February 1-28, 2026GIG HARBOR, Wash., March 06, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST) (the “Company” or “IP Strategy”), the first company to adopt a treasury reserve policy centered on the $IP token, today released its monthly publication detailing its validator business performance. The report is part of IP Strategy’s ongoing monthly publication cycle designed to provide the investment community with greater transparency into operations an ...

Quantum platform designed to accelerate development of safer, longer-lasting next-generation batteriesBuilds on growing U.S. and Canadian government momentum, with additional large-scale opportunities in the pipeline SEATTLE, March 06, 2026 (GLOBE NEWSWIRE) -- Xanadu Quantum Technologies Inc. (“Xanadu”), a leading photonic quantum computing company, announced today that it has been selected to receive $2,027,507 in funding from the U.S. Department of Energy Advanced Research Projects Agency-Energy (ARPA-E). ...

Revised Offer of $23.50 Per Share Represents 31% Premium Over Undisturbed Closing Price Prior to Initial Offer Receives Fully Underwritten Commitment for $1.433 Billion in Financing Arranged by DNB Carnegie and Nordea, and Including Other Leading International Banks Star Bulk Enters into Definitive Agreement with Diana to Acquire 16 Genco Vessels for $470.5 Million Calls Upon Genco Board to Immediately Engage in Good Faith Negotiations to Reach Definitive Agreement ATHENS, Greece, March 06, 2026 (GLOBE NEW ...

Key Takeaways Ironwood's share of Linzess U.S. net profit declined 15% year over year to $289.3M in 2025.IRWD noted that rebate adjustments and Medicare Part D pricing pressure caused the sales dip, not weak demand.Ironwood expects 2026 revenues to be in the band of $450M-$475M as Linzess sales rebound.Ironwood Pharmaceuticals’ (IRWD) sole marketed product, Linzess (linaclotide), is approved for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults and pediatric patients aged seven y ...

Key Takeaways Thermo Fisher is expanding via deals, including Clario for $8.875B and Solventum's filtration unit. TMO posted high single-digit Q4 Pharma & Biotech growth, led by bioproduction and research demand. TMO faces FX risks as global sales grow, while competition and tech shifts pressure operations.Thermo Fisher Scientific Inc.’s (TMO) recent slew of strategic acquisitions reflects its ongoing commitment to sustainable long-term growth. End markets play an important role as well, bolstering the comp ...

Key Takeaways CIEN Q1 EPS of $1.35 beat estimates as revenue jumped 33% to $1.43B on rising AI network demand.CIEN cloud provider revenue surged 76% and made up 42% of sales as hyperscalers expanded bandwidth capacity.CIEN backlog grew about $2B to $7B, with many new infrastructure orders scheduled for fiscal 2027 fulfillment.Ciena Corporation (CIEN) reported first-quarter fiscal 2026 (ended Jan. 31) adjusted earnings per share (EPS) of $1.35, which surpassed the Zacks Consensus Estimate of $1.14. The botto ...

Key Takeaways QUBT expects Luminar Semiconductor acquisition to add revenues in Q1 2026 and expand chip capabilities. Quantum Computing is ramping its Fab 1 TFLN photonic chip foundry as early revenues begin. QUBT highlighted AI infrastructure opportunities, including a partnership with POET Technologies.Quantum Computing Inc. (QUBT) highlighted several key growth drivers expected to support its expansion further in 2026. A major catalyst is the recent acquisition of Luminar Semiconductor, which closed in F ...

With just one subscription to Beyond the Wall Investing , you can save thousands of dollars a year on equity research reports from banks. You'll keep your finger on the pulse and have access to the latest and highest-quality analysis of this type of information.Oakoff Investments is a personal portfolio manager and a quantitative research analyst with 5 years helping readers find a reasonable balance between growth and value by sharing proprietary Wall Street information. He leads the investing group Beyond ...

Technology juggernaut Alphabet (NASDAQ:GOOG) continues to be a top pick of mine, Wall Street analysts, and most investors in the market. Indeed, the company's performance of late is suggestive of strong momentum, and now the question is whether this momentum will continue. Personally, I think the answer to this question is yes. Alphabet remains the world's dominant digital advertising powerhouse, with a sprawling empire that includes the likes of Google Search, YouTube, and an absolutely giant (and fast-g ...

The group of so-called "Magnificent 7†mega-cap tech giants continue to dominate the mind share of most investors, with these…## Forget Nvidia: Alphabet Is the New Hot Chip Stock to Own, ApparentlyChris MacDonald | Dec 12, 2025 at 9:01 AM EST Alphabet (NASDAQ:GOOG) could be among the most-watched mega-cap tech stocks in the market right now. Between the company's core search and…## 3 Growth Stocks With Sky-High Price Targets Investors Will LoveChris MacDonald | Aug 19, 2024 at 12:07 PM EDT The market pullbac ...